期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

G蛋白信号转导异常与阿尔茨海默病 被引量：3

Abnormalities of G protein signal transduction in AD
原文传递
导出
摘要 AD是一种以进行性认知功能减退为特征的神经退行性疾病。流行病学调查表明：在65岁以上人群中AD的发病率为5％～10％，85岁以上的老年人中发病率约为25％^［1］。随着人口老龄化趋势的进展，AD已成为威胁人类生命的主要疾病．其致死率仅次于心脏病、肿瘤和中风。AD根据家族史可分为家族性AD（FAD）和散发性AD（SAD）。
作者 阚伯红 于建春 韩景献
机构地区 天津中医药大学第一附属医院分子生物学实验室 天津市针灸研究所
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2011年第3期319-321,共3页 Chinese Journal of Neuromedicine
基金 国家自然科学基金（30772839,30873302） 天津市应用基础及前沿技术研究计划重点项目（08JCZDJCl5800）
关键词 阿尔茨海默病 淀粉样蛋白 TAU蛋白质类 Alzheimer＇s disease Amyloid beta Tau protein
分类号 R749.16 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献21

  • 1Saido TC.Towards presymptomatic diagnosis,prevention and treatment of Alzheimer's disease[J].Rinsho shinkeigaku,2004(11):824-826.
  • 2张雄,李昱.Wnt信号传导通路在阿尔茨海默病中的研究进展[J].中华神经医学杂志,2008,7(4):430-432. 被引量：5
  • 3姚丽,吴海琴,张桂莲.p38MAPK信号转导途径与阿尔茨海默病[J].实用医学杂志,2007,23(12):1939-1941. 被引量：5
  • 4García-Jiménez A,Fastbom J,Winblad B,et al.G-Protein Regulation of Signal Transduction in Alzheimer's Disease[J].Brain aging,2002,2(2):7-15.
  • 5Kim SH,Nairn AC,Cairns N,et al.Decreased levels of ARPP-19 and PKA in brains of Down syndrome and Alzheimer's disease[J].J Neural Transm Suppl,2001,61:263-272.
  • 6Kim JH,Kim HJ.Direct Involvement of G Protein q/11 Subunit in Regulation of Muscarinic Receptor-Mediated sAPP Release[J].Arch Pharm Res,2005,28(11):1275-1281.
  • 7Alkon DL,Sun MK,Nelson TJ.PKC signaling deficits:a mechanistic hypothesis for the origins of Alzheimer's disease[J].Trends Pharmacol Sci,2007,28(2):51-60.
  • 8Rosenberg M,Ravid S.Protein kinase Cgamma regulates myosin Ⅱ B phosphorylation,cellular localization,and filament assembly[J].Mol Biol Cell,2006,17(3):1364-1374.
  • 9Argellati F,Domenicotti C,Passalacqua M,Protein kinase C-dependent alpha-secretory processing of the amyloid precursor protein is mediated by phosphorylation of myosin Ⅱ-B[J].FASEB J,2009,23(4):1246-1251.
  • 10Massone S,Argellati F,Passalacqua M.Downregulation of myosin Ⅱ -B by siRNA alters the subcellular localization of the amyloid precursor protein and increases amyloid-beta deposition in N2a cells[J].Biochem Biophys Res Commun,2007,362(3):633-638.

二级参考文献42

  • 1Aquilera O, Munoz A, Esteller M, et al. Epigenetic alterations of the Wnt/beta-catenin pathway in human disease [J]. Endocr Metab Immune Disord Drug Targets, 2007, 7(1 )- 13-21.
  • 2Nam JS, Turcotte TJ, Smith PF, et al. Mouse cfistin/R-spondin family proteins are novel ligands for the Frizzled 8 and LRP6 receptors and activate beta-catenin-dependent gene expression[J]. J Biol Chem, 2006, 281(19): 13247-13257.
  • 3Fogarty M, Kessler J, Wechsler-Reya R. Morphing into cancer:the role of developmental signaling pathways in brain tumor formation [J]. J Neurobiol, 2005, 64(4): 458-475.
  • 4Calvisi DF, Ladu S, Factor VM, et al. Activation of beta- catenin provides proliferative and invasive advantages in c-myc/TGF-alpha hepatocarcinogenesis promoted by phenobarbital [J]. Carcinogenesis, 2004, 25(6): 901-908.
  • 5De Ferrari GV, Moon RT. The ups and downs of Wnt signaling in prevalent neurologicaldisorders [J]. Oncogene, 2006, 25 (57): 7545-7553.
  • 6Duvoix A, Blasius R, Delhalle S, et al. Chemopreventive and therapeutic effects ofcurcumin [J]. Cancer Lett, 2005, 223 (2): 181-190.
  • 7Pugh PL, Richardson JC, Bate ST, et al. Non-cognitive behaviours in an APP/PS 1 transgenic model of Alzheimer' s disease [J]. Behav Brain Res, 2007, 178(1): 18-28.
  • 8Kang DE, Soriano S, Xia X, et al. Presenilin couples the paired phosphorylation of β-catenin independent of axin: implications for β-catenin activation in tumorigenesis [J]. Ceff, 2002, 110 (6): 751-762.
  • 9Baki L, Marambaud P, Efehimiopoulos S, et al. Presenilin-1 binds cytoplastic epithehal cadherin inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex[J]. PNAS, 2001,98(2): 2381-2386.
  • 10Marambaud P, Shioi J, Serban G, et al. A presenilin1/γ-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly ofadherens functions [J]. EMBO J, 2002, 21 (8): 1948-1954.

共引文献8

同被引文献57

  • 1周晓雯,苏朝芬,罗焕敏.线粒体与神经退行性疾病[J].神经药理学报,2011(3):41-46. 被引量：5
  • 2李晓辉.G蛋白亚单位基因家族等信号转导分子研究进展[J].解放军药学学报,2004,20(3):205-208. 被引量：8
  • 3Gillies GE, McArthur S. Estrogen actions in the brain and the basis for differential action in men and women: a case for sex-specific medicines[J]. Pharmacol Rev, 2010, 62(2): 155-198.
  • 4Tian Y, Crump CJ, Li YM. Dual role of alpha-secretase cleavage in the regulation of gamma-secretase activity for amyloid production [J]. J Biol Chem, 2010, 285(42): 32549-32556.
  • 5Woo HN, Baik SH, Park JS, et al. Secretases as therapeutic targets for Alzheimer's disease[J]. Biochem Biophys Res Commun, 2011, 404(1): 10-15.
  • 6Vifia J, Lloret A. Why women have more Alzheimer's disease than men: gender and mitochondrial toxicity of amyloid-beta peptide [J]. J Alzheimers Dis, 2010, 20 Suppl 2: S527-533.
  • 7Pike CJ, Carroll JC, Rosario ER, et al. Protective actions of sex steroid hormones in Alzheimer' s disease [J]. Front Neuroendocrinol, 2009, 30(2): 239-258.
  • 8Fernandez JW, Rezai-Zadeh K, Obregon D, et al. EGCG functions through estrogen receptor-mediated activation of ADAM10 in the promotion of non-amyloidogenic processing of APP[J]. FEB S Lett, 2010, 584(19): 4259-4267.
  • 9Koyama S, Wada-Hiraike O, Nakagawa S, et al. Repression of estrogen receptor beta function by putative tumor suppressor DBC 1 [J]. Biochem Biophys Res Commun, 2010, 392(3): 357-362.
  • 10Lambertini E, Tavanti E, Torreggiani E, et al. ERalpha and AP-1 interact in vivo with a specific sequence of the F promoter of the human ERalpha gene in osteoblasts[J]. J Cell Physiol, 2008, 216 (1): 101-110.

引证文献3

二级引证文献3

中华神经医学杂志
2011年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部